Checkpoint immunotherapy is enhanced when CD8+ T cells and T regulatory cells are "cut off.".

Published Date: 12 Jun 2024

The accepted approach to treating metastatic melanoma now involves checkpoint immunotherapy with PD-1 blockade. Although forty percent of patients respond well to this treatment, the other sixty percent experience resistance, which results in tumor regrowth.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot